Renaissance Technologies
INM icon

Renaissance Technologies’s InMed Pharmaceuticals INM Stock Holding History

Renaissance Technologies’s Portfolio INM Stock Details INM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,680
Closed -$36.8K – 3483
2025
Q3 		$36.8K Buy
+1,680
New +$40.5K ﹤0.01% 3380
2024
Q4 		– Sell
-251
Closed -$11.9K – 3727
2024
Q3 		$11.9K Buy
+251
New +$12.8K ﹤0.01% 3453
2024
Q2 		– Sell
-142
Closed -$10K – 3721
2024
Q1 		$10K Sell
142
-53
-27% -$3.9K ﹤0.01% 3623
2023
Q4 		$16K Buy
+195
New +$18.9K ﹤0.01% 3603
2023
Q2 		– Sell
-388
Closed -$84K – 4082
2023
Q1 		$84K Buy
+388
New +$125K ﹤0.01% 3540
2022
Q3 		– Sell
-10
Closed -$23K – 4213
2022
Q2 		$23K Buy
10
+1
+11% +$3.83K ﹤0.01% 4105
2022
Q1 		$43K Hold
9
– – ﹤0.01% 3931
2021
Q4 		$58K Buy
+9
New +$69.6K ﹤0.01% 3768

Other funds holding INM

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Federation des caisses Desjardins du Quebec
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Renaissance Technologies's INM Position: Q4 2025 in Review

Renaissance Technologies sold out of InMed Pharmaceuticals (INM) in Q4 2025, closing a stake of 1,680 shares — an estimated $36.8K sold.

Renaissance Technologies first reported a position in INM in Q4 2021 and held it in 8 quarters. The position peaked at $84K in Q1 2023. 6 funds tracked by Wall St. Rank hold INM as of Q4 2025.

  • Renaissance Technologies reported no remaining InMed Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Renaissance Technologies sold 1,680 InMed Pharmaceuticals shares in Q4 2025, an estimated $36.8K.
  • Renaissance Technologies first reported a position in InMed Pharmaceuticals in Q4 2021 and held it in 8 quarters.
  • Renaissance Technologies's InMed Pharmaceuticals position peaked at $84K in Q1 2023.
  • 6 funds tracked by Wall St. Rank held InMed Pharmaceuticals as of Q4 2025.

Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.